Form 4: Mangoceuticals Director Acquires Shares for Services Rendered

Kenny Myers, a director at Mangoceuticals, acquired 100,000 shares of common stock as compensation for board services.

Summary

• On June 3, 2024, Kenny Myers, a director of Mangoceuticals, acquired 100,000 shares of common stock.
• The shares were issued in consideration for services rendered as a member of the Board of Directors.
• The acquisition was made under the registrant's Amended and Restated 2022 Equity Incentive Plan and is exempt pursuant to Rule 16b-3.
• Following the transaction, Myers beneficially owns 175,000 shares.

Sentiment

Score: 6

Explanation: Neutral sentiment as it reflects a standard compensation practice. The director's increased stake could be seen as a positive signal, but it's a routine transaction.

Positives

• The acquisition of shares by a director demonstrates alignment with the company's interests.

Industry Context

Directors receiving stock compensation is a common practice in publicly traded companies to align their interests with those of shareholders.

Stakeholder Impact

• The transaction could have a slightly positive impact on shareholders as it aligns the director's interests with theirs.

Key Dates

Keywords

Mangoceuticals, MGRX, Kenny Myers, Director, Stock Acquisition, Form 4, Equity Incentive Plan, Beneficial Ownership